Mathur, Rohan
Yellapantula, Sudha
Cheng, Lin
Dziedzic, Peter
Potu, Niteesh
Calvillo, Eusebia
Shah, Vishank
Lefebvre, Austen
Bosel, Julian
Zink, Elizabeth K.
Muehlschlegel, Susanne
Suarez, Jose I.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (Award T32- 423 GM075774-16)
STAAR15 Grant (Mentored Research Award), Department of Anesthesiology & Critical Care Medicine, Johns Hopkins University School of Medicine
Article History
Received: 10 October 2024
Accepted: 2 April 2025
First Online: 11 April 2025
Competing interests
: The authors declare no competing financial or non-financial interests that have a relationship to this work as defined by Nature Portfolio. The authors declare the following non-competing disclosures: Vishank Shah disclosures: VS received honoraria (<1000$) from Astra Zeneca and serves on the Editorial Board for Neurohospitalist. Sudha Yellapantula works as a Researcher for Medical Informatics Corp (MIC, Houston TX) and reports no competing interests. MIC is a company that provides the Sickbay platform to various hospitals, for clinical and research use of the data. Medical Informatics provided no funding and/or support for the study. Jose I Suarez disclosures: ex-officio member of the Board of Directors of the Neurocritical Care Society; member of the Scientific Advisory Board for Cyban; Member of the Data Safety Monitoring Board for clinical trials sponsored by Acasti and Perfuze; member of the Advisory Board for AstraZeneca for Andexxa Medical Strategy. Susanne Muehlschlegel disclosures: ex-officio member of the Board of Directors of the Neurocritical Care Society; Consultant for Acasti Pharma as a member of the clinical endpoint adjudication committee. Has received speaking and writing honoraria from the American Academy of Neurology. Serves on the Editorial Board for Neurocritical Care and Stroke (unpaid).